|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.825 USD | +4.44% |
|
-0.10% | +13.63% |
| Apr. 25 | Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer | RE |
| Apr. 22 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
April 2 (Reuters) - The U.S. FDA approved Vanda Pharmaceuticals' drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the treatment.
(Reporting by Christy Santhosh and Vaibhav Sadhamta in Bengaluru; Editing by Maju Samuel)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.63% | 266M | |
| -2.82% | 103B | |
| +1.39% | 95.28B | |
| +1.46% | 22.15B | |
| -16.09% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.13% | 16.05B | |
| +5.62% | 13.68B | |
| +33.50% | 12.17B |
VANDA PHARMACEUTICALS INC. 
